Bär & Karrer advised Swiss vehicle manufacturer Aebi Schmidt on its merger with the U.S. specialty vehicle manufacturer The Shyft Group, advised by Lenz & Staehelin. Niederer Kraft Frey advised UBS Switzerland as
Tags :Lukas Aebi
Starrag and Tornos, the two traditional Swiss precision machine tool manufacturers, both listed at the SIX Swiss Exchange, announced on October 26, 2023 that they entered into a merger agreement. Under the terms of the merger, Tornos
Q-SYS, a division of US-based QSC, has announced a definitive agreement to acquire Seervision, a Swiss-based industry pioneer in AI-driven camera automation software. The acquisition accelerates the Q-SYS strategy to develop and deliver a scalable
Emergent BioSolutions, the New York Stock Exchange listed developer and manufacturer of vaccines, completed the sale of its travel vaccine business to Bavarian Nordic for an upfront payment of USD 270 million. At closing Emergent received
Swiss Prime Site signed an agreement to sell its Wincasa group company, its real-estate services business, to Implenia for an enterprise value of CHF 235 million. Subject to regulatory approval, the transaction is expected to close
The automotive supplier BorgWarner has acquired the Switzerland-based Drivetek. The transaction has an enterprise value of up to CHF 35 million, of which CHF 25 million was delivered at closing. An additional CHF 10 million could be paid
Credit Suisse Asset Management has sold its minority stake in Energy Infrastructure Partners to the company’s co-founders and managing partners for an undisclosed consideration. Energy Infrastructure Partners was established in 2014 as a joint venture
ImmunOs Therapeutics has closed an oversubscribed Series B financing round totaling USD 74 million. The round was led by new investors Samsara BioCapital, Lightspeed Venture Partners, and Gimv, and joined by new investors Mission BioCapital, GL
Taro Pharmaceutical Industries, a multinational, science-based pharmaceutical company, and Swiss-based Galderma have signed a definitive agreement for Taro to acquire Alchemee, formerly The Proactiv Company, from Galderma. The agreement includes Alchemee’s business and assets
On October 27, 2021, Skan Group has announced the pricing of its IPO, consisting of 1,731,494 newly issued shares and 2,768,506 existing shares and an over-allotment option of up to 500,000 shares, at CHF 54 per share, implying a total market
